Ishak WW - Search Results

1

A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.

Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. Papakostas GI, et al. Among authors: ishak ww. J Clin Psychiatry. 2012 Dec;73(12):1541-7. doi: 10.4088/JCP.12m07670. J Clin Psychiatry. 2012. PMID: 23290327 Clinical Trial.

2

The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.

IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I. IsHak WW, et al. Innov Clin Neurosci. 2023 Spring;20(4-6):39-48. Innov Clin Neurosci. 2023. PMID: 37387703 Free PMC article. Review.

3

The effectiveness of atypical antipsychotic medications in depressive disorders.

Ishak WW, Rapaport MH, Gotto JG. Ishak WW, et al. Curr Psychiatry Rep. 2004 Dec;6(6):422-4. doi: 10.1007/s11920-004-0005-0. Curr Psychiatry Rep. 2004. PMID: 15538989 Review.

4

The role of dopaminergic agents in improving quality of life in major depressive disorder.

IsHak WW, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport MH. IsHak WW, et al. Curr Psychiatry Rep. 2009 Dec;11(6):503-8. doi: 10.1007/s11920-009-0076-z. Curr Psychiatry Rep. 2009. PMID: 19909674 Review.

5

Treating major depression by creating positive expectations for the future: a pilot study for the effectiveness of future-directed therapy (FDT) on symptom severity and quality of life.

Vilhauer JS, Young S, Kealoha C, Borrmann J, IsHak WW, Rapaport MH, Hartoonian N, Mirocha J. Vilhauer JS, et al. Among authors: ishak ww. CNS Neurosci Ther. 2012 Feb;18(2):102-9. doi: 10.1111/j.1755-5949.2011.00235.x. CNS Neurosci Ther. 2012. PMID: 21615882 Free PMC article.

6

Quality of life: the ultimate outcome measure of interventions in major depressive disorder.

IsHak WW, Greenberg JM, Balayan K, Kapitanski N, Jeffrey J, Fathy H, Fakhry H, Rapaport MH. IsHak WW, et al. Harv Rev Psychiatry. 2011 Sep-Oct;19(5):229-39. doi: 10.3109/10673229.2011.614099. Harv Rev Psychiatry. 2011. PMID: 21916825 Review.

7

Attitude toward humor in patients experiencing depressive symptoms.

Bokarius A, Ha K, Poland R, Bokarius V, Rapaport MH, Ishak WW. Bokarius A, et al. Among authors: ishak ww. Innov Clin Neurosci. 2011 Sep;8(9):20-3. Innov Clin Neurosci. 2011. PMID: 22010061 Free PMC article.

8

The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression.

Ishak WW, Ha K, Kapitanski N, Bagot K, Fathy H, Swanson B, Vilhauer J, Balayan K, Bolotaulo NI, Rapaport MH. Ishak WW, et al. Harv Rev Psychiatry. 2011 Nov-Dec;19(6):277-89. doi: 10.3109/10673229.2011.630828. Harv Rev Psychiatry. 2011. PMID: 22098324 Review.

9

A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.

Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH. Ishak WW, et al. Qual Life Res. 2013 Apr;22(3):585-96. doi: 10.1007/s11136-012-0187-6. Epub 2012 Apr 29. Qual Life Res. 2013. PMID: 22544416

10

Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.

Ishak WW, Christensen S, Sayer G, Ha K, Li N, Miller J, Nguyen JM, Cohen RM. Ishak WW, et al. J Clin Psychiatry. 2013 Mar;74(3):256-61. doi: 10.4088/JCP.12m07933. J Clin Psychiatry. 2013. PMID: 23561231 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters